The Healthcare Businesswomen's Association named Siren Interactive founder and president Wendy White to its board of directors executive committee.

Teva named former Bristol-Myers Squibb exec Dr. Jeremy Levin to replace Shlomo Yanai, who is retiring from his role as president and CEO of the generics giant in May.

Vertex CEO Matthew Emmens is stepping down from that post after the company's best year ever and amid skyrocketing sales of its hepatitis C drug Incivek.

Pfizer's board of directors elected CEO Ian Read chairman, succeeding George Lorch in that post.

Adrian Adams was appointed CEO and president of Auxilium Pharmaceuticals, effective immediately, succeeding Armando Anido, who, after discussions with the company's board agreed to step down from that role.

Brian McGowan, Pfizer's senior director of education, oncology, in the medical education grants group, said he is leaving the company tomorrow.

Genzyme named William "Bill" Sibold as head of multiple sclerosis and Rogério Vivaldi as head of rare diseases, two businesses the firm says constitute its core focus following the integration with Sanofi.

Muckraking pharma critic Paul Thacker is leaving the Project on Government Oversight, where he has been an investigator for a year since leaving the Senate, to serve as chief of investigations at United Republic.

Lilly named Lilly USA president Dave Ricks SVP and president of Lilly Bio-Medicines, in which role he'll succeed Bryce Carmine, who is retiring.

Boston Scientific named J&J devices chief Michael Mahoney president and, eventually, CEO.

Sunovion Pharmaceuticals has announced that Mark Iwicki, formerly president and chief operating officer at Sunovion, has been appointed as the company's president and CEO.

Sunovion Pharmaceuticals has announced that Mark Iwicki, formerly president and chief operating officer at Sunovion, has been appointed as the company's president and CEO.

Sanofi Pasteur named Chad Hoover VP, chief commercial officer for Sanofi Pasteur US, with responsibility for day-to-day management of commercial operations for the US vaccines business.

GlaxoSmithKline Consumer Healthcare has announced the appointment of John Graham to the position of chief marketing officer (CMO) for Consumer Healthcare, North America (CHNA), which encompasses such consumer brands as Aquafresh and Sensodyne toothpastes and Tums antacid.

Roche named Mara Aspinall president of Ventana Medical Systems.

Michel Nakache has been brought on by McCann Healthcare Worldwide as EVP Europe.

BIO, the Biotech Industry Organization, named Human Genome Sciences chief H. Thomas Watkins chairman of the board for 2011-2012.

The American Medical Association named James Madara EVP and CEO.

Merck KGaA's EMD Serono announced on Friday that president Fereydoun Firouz had resigned from his positions there "to pursue other professional opportunities" after 22 years with the company.

Sanofi Pasteur named Damian Braga global head of commercial operations. Braga, who was previously president of Sanofi Pasteur US and VP Americas, will have responsibility for more than $5 billion in annual revenue from operations in 100 countries in his new post as SVP commercial operations, vaccines.